2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

Volume: 119, Issue: 7, Pages: 1135 - 1157
Published: Jul 1, 2020
Abstract
Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been reported in Taiwan, especially in high-risk populations including people who inject drugs (PWID) and patients requiring dialysis. Besides, certain populations merit special considerations due to suboptimal outcome, potential drug-drug interaction, or possible side...
Paper Details
Title
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
Published Date
Jul 1, 2020
Volume
119
Issue
7
Pages
1135 - 1157
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.